News
Meanwhile, sales of gene therapy Zolgensma for spinal muscular atrophy shot up more than 50% to $315 million ... Bristol-Myers Squibb’s Sprycel (dasatinib) and Novartis’ Tasigna (nilotinib ...
Ashlee is an insurance editor, journalist and business professional with an MBA and more than 17 years of hands-on experience in both business and personal finance. She is passionate about ...
Invest in the best stocks under $50 with Interactive Brokers for fast trade execution. You don’t need thousands of dollars in the bank to get started investing. Just $50, or less, can help you ...
France 50 Year Government Bond-0.0110 3.6961% ...
Fund manager updated portfolio more frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for shorter duration than peers) ...
Fund manager updated portfolio more frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for shorter duration than peers) ...
Rare disease patients demand compulsory licensing for life-saving drugs: Here’s why it’s significant
Petition in Karnataka HC asks Govt to invoke compulsory licensing clause that grants someone other than the patent holder the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results